Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep;37(Suppl 3):476-483.
doi: 10.1007/s12055-021-01175-4. Epub 2021 Apr 27.

Extracorporeal life support during lung transplantation

Affiliations
Review

Extracorporeal life support during lung transplantation

Jenalee Nicole Coster et al. Indian J Thorac Cardiovasc Surg. 2021 Sep.

Abstract

Lung transplantation surgeries are performed without extracorporeal life support (ECLS) by using an off-pump technique; however, in cases of hypoxemia or hemodynamic instability, intraoperative ECLS may be required. Cardiopulmonary bypass (CPB) has traditionally been the standard practice for ECLS but has been associated with an increased risk of bleeding in the perioperative period, increased transfusion requirements, prolonged postoperative intubation, and possibly primary graft dysfunction. More recently, because of the flexibility of using extracorporeal membrane oxygenation (ECMO) in bridging to transplantation and during postoperative recovery, its use has increased. CPB and ECMO each has advantages and disadvantages; however, because comparisons of CPB and ECMO have been limited to small retrospective observational and single-institution studies, more research is required to determine the superiority of one modality. In this review, we critically examine the pros and cons of performing lung transplantation surgery off-pump or by using the ECLS modalities of ECMO and CPB support during lung transplantation surgery.

Keywords: Cardiopulmonary bypass; ECMO; Extracorporeal life support; Lung transplantation.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestDr Gabriel Loor is a consultant for Abiomed. Institution receives grant support for ECMO and cardiothoracic research from Maquet, Medtronic, Transmedics, and St. Jude.

Similar articles

Cited by

References

    1. Diamond JM, Lee JC, Kawut SM, Shah RJ, Localio AR, Bellamy SL, Lederer DJ, Cantu E, Kohl BA, Lama VN, Bhorade SM, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Shah AS, Weinacker A, Arcasoy S, Shah PD, Wilkes DS, Ware LB, Palmer SM, Christie JD, for the Lung Transplant Outcomes Group Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2013;187(5):527–534. doi: 10.1164/rccm.201210-1865OC. - DOI - PMC - PubMed
    1. Baez B, Castillo M. Anesthetic considerations for lung transplantation. Semin Cardiothorac Vasc Anesth. 2008;12(2):122–127. doi: 10.1177/1089253208319871. - DOI - PubMed
    1. Roberts JD, Minhaj M, Chaney MA. Anesthesia for lung transplantation. In: Vigneswaren WT, Garrity ER, Odell JA, editors. Lung transplantation: principles and practice. 1. Boca Raton: CRC Press; 2020.
    1. Perrin G, Roch A, Michelet P, Reynaud-Gaubert M, Thomas P, Doddoli C, Auffray JP. Inhaled nitric oxide does not prevent pulmonary edema after lung transplantation measured by lung water content: a randomized clinical study. Chest. 2006;129(4):1024–1030. doi: 10.1378/chest.129.4.1024. - DOI - PubMed
    1. Raffin L, Michel-Cherqui M, Sperandio M, Bonnette P, Bisson A, Loirat P, Fischler M. Anesthesia for bilateral lung transplantation without cardiopulmonary bypass: initial experience and review of intraoperative problems. J Cardiothorac Vasc Anesth. 1992;6(4):409–417. doi: 10.1016/1053-0770(92)90005-r. - DOI - PubMed

LinkOut - more resources